Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 753 | 1,747 | 3,381 | 6,540 | 11,129 |
| Cost of Goods | 334 | 1,452 | 2,845 | 5,639 | 8,255 |
| Gross Profit | 419 | 295 | 536 | 901 | 2,874 |
| Operating Expenses | 21,919 | 20,736 | 23,328 | 22,629 | 21,050 |
| Operating Income | -21,166 | -19,989 | -21,947 | -21,089 | -17,921 |
| Interest Expense | 555 | 2,206 | 1,005 | 891 | 1,863 |
| Other Income | 2,630 | 1,413 | 2,125 | 2,424 | 2,571 |
| Pre-tax Income | -19,091 | -20,782 | -20,827 | -19,556 | -17,213 |
| Income Tax | 24 | 30 | 11 | 36 | N/A |
| Net Income Continuous | -19,115 | -20,812 | -20,838 | -19,592 | -17,213 |
| Minority Interests | -1,003 | -54 | N/A | N/A | N/A |
| Net Income | $-18,112 | $-20,758 | $-20,838 | $-19,592 | $-17,213 |
| EPS Basic Total Ops | -7.00 | -8.10 | -8.10 | -7.70 | -6.80 |
| EPS Basic Continuous Ops | -7.42 | -8.08 | -8.12 | -7.70 | -6.78 |
| EPS Diluted Total Ops | -7.00 | -8.10 | -8.10 | -7.70 | -6.80 |
| EPS Diluted Continuous Ops | -7.42 | -8.08 | -8.12 | -7.70 | -6.78 |
| EPS Diluted Before Non-Recurring Items | -7.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-18,397 | $-17,969 | $-19,802 | $-18,810 | $-15,488 |